Paragon Capital Management (Utah)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2M Sell
2,286
-29
-1% -$16.3K 0.89% 39
2026
Q1
$1.3M Sell
2,315
-701
-23% -$450K 1.1% 26
2025
Q4
$2.04M Sell
3,016
-451
-13% -$307K 1.58% 14
2025
Q3
$2.22M Sell
3,467
-179
-5% -$109K 1.66% 14
2025
Q2
$1.96M Sell
3,646
-83
-2% -$39.7K 1.49% 16
2025
Q1
$1.57M Sell
3,729
-91
-2% -$39.5K 1.26% 24
2024
Q4
$1.58M Buy
3,820
+782
+26% +$343K 1.23% 29
2024
Q3
$1.53M Buy
3,038
+14
+0.5% +$6.8K 1.13% 39
2024
Q2
$1.47M Buy
3,024
+86
+3% +$43.2K 1.12% 35
2024
Q1
$1.59M Sell
2,938
-34
-1% -$18.6K 1.19% 38
2023
Q4
$1.65M Buy
2,972
+134
+5% +$62.9K 1.32% 22
2023
Q3
$1.24M Buy
2,838
+65
+2% +$32.4K 1.06% 38
2023
Q2
$1.39M Sell
2,773
-36
-1% -$17.3K 1.18% 27
2023
Q1
$1.4M Sell
2,809
-130
-4% -$62.2K 1.22% 22
2022
Q4
$1.2M Buy
2,939
+12
+0.4% +$4.66K 1.12% 26
2022
Q3
$954K Buy
2,927
+60
+2% +$22K 0.93% 41
2022
Q2
$1.01M Buy
2,867
+542
+23% +$221K 1.02% 39
2022
Q1
$1.27M Buy
2,325
+36
+2% +$18.9K 1.18% 33
2021
Q4
$1.51M Buy
+2,289
New +$1.44M 1.29% 26

Other funds holding IDXX

Paragon Capital Management (Utah)'s IDXX Position: Q2 2026 in Review

Paragon Capital Management (Utah) reduced its Idexx Laboratories (IDXX) stake by 1.3% in Q2 2026, selling an estimated $16.3K and leaving 2,286 shares worth $1.2M. The position accounts for 0.89% of the portfolio, ranked #39.

Paragon Capital Management (Utah) first reported a position in IDXX in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.22M in Q3 2025. 659 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Paragon Capital Management (Utah) held 2,286 shares of Idexx Laboratories worth $1.2M as of Q2 2026.
  • Paragon Capital Management (Utah) sold 29 Idexx Laboratories shares in Q2 2026, an estimated $16.3K.
  • Idexx Laboratories made up 0.89% of Paragon Capital Management (Utah)'s portfolio in Q2 2026, its #39 holding.
  • Paragon Capital Management (Utah) first reported a position in Idexx Laboratories in Q4 2021 and has held it in 19 quarters since.
  • Paragon Capital Management (Utah)'s Idexx Laboratories position peaked at $2.22M in Q3 2025.
  • 659 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Paragon Capital Management (Utah)'s 13F filing for Q2 2026, filed 22 Jul 2026.